Image Caption: (L-R) Mr Ajay Singh Parihar, Vice President, Marketing Dabur India Limited; Mr Debarshi Duttagupta, Managing Director, East India Pharmaceuticals; Prof. Manoshi Roychowdhury, Co-Chairperson Techno India Group; Mr Prashant Sharma, Chairman, CII Healthcare Subcommittee & Managing Director Charnock Hospitals; Ms Dhivya Loganathan, IAS Special Secretary, Department of Health & Family Welfare & DG AYUSH, Government of West Bengal; Mr Sharad Kumar Dwivedi, IAS Secretary Department of Health & Family Welfare, Government of West Bengal; Mr Prithish Chowdhary, Co-Chairman, CII Manufacturing Subcommittee & Deputy Managing Director, Titagarh Rail System; Ms Neha Sharma, President, Baidyanath Ayurved & Director, Goodcare Pharma; Dr Yadu Mooss, Director, Vaidyaratnam Ayurveda; Mr Sudipta Chakraborty, Deputy Director, CII Eastern Region at the CII Ayush Manufacturing Conclave 2025.
Ayush sector in India has witnessed remarkable growth, with its market size expanding from $3 billion in 2014 to $24 billion in 2023 registering a CAGR of 17 per cent. Understanding the importance, CII Eastern Region organised the maiden edition of Ayush Manufacturing Conclave 2025, today in Kolkata.
Collaboration between traditional and modern medicine is the need of the hour, said Mr Sharad Kumar Dwivedi, IAS, Secretary, Department of Health & Family Welfare Government of West Bengal in the CII Conclave. He highlighted plans to develop a medicinal plant cluster and establish health and wellness centres in hilly regions and tea gardens, aiming to leverage the state’s growing potential in medical value travel.
Strengthening infrastructure and increasing investment in research and development remain central priorities for the state government said Ms Dhivya Loganathan, IAS, Special Secretary, Department of Health & Family Welfare & DG AYUSH, Government of West Bengal. She also outlined that the state currently has three Ayush colleges, four homeopathy colleges and ten Ayush hospitals.
While outlining the state of Kerala’s AYUSH sector, Dr Yadu Mooss, Director, Vaidyaratnam Ayurveda, noted a 20 per cent decline in registered Ayurvedic units in the post-Covid period. He further emphasized the rising demand for contract farming in the state and the increasing integration of Ayush with allopathic care in hospitals.
Prof. Manoshi Roychowdhury, Co-Chairperson, Techno India Group highlighted the rising demand for natural, plant-based medicinal products. Meanwhile, Dr Sudipta Narayan Roy, Managing Director, Powell Group emphasized the export potential of Ayush products from West Bengal to Southeast Asian markets, envisioning the state as an Ayush export corridor. He stressed that Brand Bengal – Make in India – Trusted by the World should be the guiding motto for the state’s Ayush export initiatives.
The sessions were followed by the recognition of excellence in Ayush sector, and the conclave witnessed the presence of major industry stakeholders.
https://shorturl.fm/TRys2